Immucell Stock Technical Analysis

ICCC Stock  USD 6.04  0.33  5.18%   
As of the 29th of January, ImmuCell retains the Downside Deviation of 3.71, market risk adjusted performance of 0.0102, and Risk Adjusted Performance of 0.0101. ImmuCell technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.

ImmuCell Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as ImmuCell, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to ImmuCellImmuCell's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.
Will Stock sector continue expanding? Could ImmuCell diversify its offerings? Factors like these will boost the valuation of ImmuCell. Market participants price ImmuCell higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every ImmuCell data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Understanding ImmuCell requires distinguishing between market price and book value, where the latter reflects ImmuCell's accounting equity. The concept of intrinsic value—what ImmuCell's is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push ImmuCell's price substantially above or below its fundamental value.
Please note, there is a significant difference between ImmuCell's value and its price as these two are different measures arrived at by different means. Investors typically determine if ImmuCell is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, ImmuCell's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.

ImmuCell 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to ImmuCell's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of ImmuCell.
0.00
10/31/2025
No Change 0.00  0.0 
In 3 months and 1 day
01/29/2026
0.00
If you would invest  0.00  in ImmuCell on October 31, 2025 and sell it all today you would earn a total of 0.00 from holding ImmuCell or generate 0.0% return on investment in ImmuCell over 90 days. ImmuCell is related to or competes with Equillium, Cue Biopharma, OUTLOOK THERAPEUTICS, Coeptis Therapeutics, OS Therapies, NRX Pharmaceuticals, and Fortress Biotech. ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and... More

ImmuCell Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure ImmuCell's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess ImmuCell upside and downside potential and time the market with a certain degree of confidence.

ImmuCell Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for ImmuCell's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as ImmuCell's standard deviation. In reality, there are many statistical measures that can use ImmuCell historical prices to predict the future ImmuCell's volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of ImmuCell's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.000.003.58
Details
Intrinsic
Valuation
LowRealHigh
0.000.003.58
Details
Naive
Forecast
LowNextHigh
2.816.409.98
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
5.826.336.85
Details

ImmuCell January 29, 2026 Technical Indicators

ImmuCell Backtested Returns

At this point, ImmuCell is out of control. ImmuCell holds Efficiency (Sharpe) Ratio of close to zero, which attests that the entity had a close to zero % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for ImmuCell, which you can use to evaluate the volatility of the firm. Please check out ImmuCell's Risk Adjusted Performance of 0.0101, market risk adjusted performance of 0.0102, and Downside Deviation of 3.71 to validate if the risk estimate we provide is consistent with the expected return of 0.0105%. The company retains a Market Volatility (i.e., Beta) of 1.98, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, ImmuCell will likely underperform. ImmuCell right now retains a risk of 3.58%. Please check out ImmuCell maximum drawdown, semi variance, and the relationship between the sortino ratio and potential upside , to decide if ImmuCell will be following its current trending patterns.

Auto-correlation

    
  -0.5  

Modest reverse predictability

ImmuCell has modest reverse predictability. Overlapping area represents the amount of predictability between ImmuCell time series from 31st of October 2025 to 15th of December 2025 and 15th of December 2025 to 29th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of ImmuCell price movement. The serial correlation of -0.5 indicates that about 50.0% of current ImmuCell price fluctuation can be explain by its past prices.
Correlation Coefficient-0.5
Spearman Rank Test-0.09
Residual Average0.0
Price Variance0.07
ImmuCell technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of ImmuCell technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of ImmuCell trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

ImmuCell Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of ImmuCell volatility. High ATR values indicate high volatility, and low values indicate low volatility.

About ImmuCell Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of ImmuCell on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of ImmuCell based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on ImmuCell price pattern first instead of the macroeconomic environment surrounding ImmuCell. By analyzing ImmuCell's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of ImmuCell's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to ImmuCell specific price patterns or momentum indicators. Please read more on our technical analysis page.

ImmuCell January 29, 2026 Technical Indicators

Most technical analysis of ImmuCell help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for ImmuCell from various momentum indicators to cycle indicators. When you analyze ImmuCell charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

ImmuCell January 29, 2026 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as ImmuCell stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

Complementary Tools for ImmuCell Stock analysis

When running ImmuCell's price analysis, check to measure ImmuCell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ImmuCell is operating at the current time. Most of ImmuCell's value examination focuses on studying past and present price action to predict the probability of ImmuCell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ImmuCell's price. Additionally, you may evaluate how the addition of ImmuCell to your portfolios can decrease your overall portfolio volatility.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like